09:48 AM EST - Acerus Pharmaceuticals Corporation : Has entered into an amending agreement with First Generation Capital Inc., a company affiliated with the Chairman of the Board of Directors of Acerus, to increase the existing subordinated secured loan facility from $15 million U.S. to $25 million U.S. This increase will be made available to the Company by way of one or more advances under a secured grid promissory note with First Generation provided that any such advance will be made before February 1, 2022. Acerus Pharmaceuticals Corporation
shares T.ASP are trading unchanged at $0.03.